Leuprorelin acetate Prescribing at SKERNE MEDICAL GROUP
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
239
Total Quantity
239
NHS Cost
£37.9K
vs National Avg
+415.7%
SKERNE MEDICAL GROUP prescribed 239 items of Leuprorelin acetate over the last 12 months at a cost of £37,882 to the NHS. This is 415.7% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
1
Jul 2026
55
Jul 2026
17
Jul 2026
1
Jul 2026
16
Jul 2026
46
Jul 2026
37
Jul 2026
19
Jul 2026
19
Jul 2026
19
Jul 2026
9
Prescribing Details
| Total Items | 239 |
|---|---|
| Total Quantity | 239 |
| Total NHS Cost | £37,882 |
| Presentations | 6 different forms |
| vs National Average | +415.7% |
Leuprorelin acetate Prescribing Comparison
| This practice | 239 items |
|---|---|
| National average per practice | 46 items |
| Difference | +415.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.